Cargando…

HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma

High mobility group protein A2 (HMGA2) is a transcription factor that plays an important role in the invasion and metastasis of gastric carcinoma (GC). The term vasculogenic mimicry (VM) refers to the unique ability of aggressive tumour cells to mimic the pattern of embryonic vasculogenic networks....

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Junying, Sun, Baocun, Sun, Ran, Zhu, Dongwang, Zhao, Xiulan, Zhang, Yanhui, Dong, Xueyi, Che, Na, Li, Jing, Liu, Fang, Zhao, Nan, Wang, Yong, Zhang, Danfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440402/
https://www.ncbi.nlm.nih.gov/pubmed/28533522
http://dx.doi.org/10.1038/s41598-017-02494-6
_version_ 1783238046710235136
author Sun, Junying
Sun, Baocun
Sun, Ran
Zhu, Dongwang
Zhao, Xiulan
Zhang, Yanhui
Dong, Xueyi
Che, Na
Li, Jing
Liu, Fang
Zhao, Nan
Wang, Yong
Zhang, Danfang
author_facet Sun, Junying
Sun, Baocun
Sun, Ran
Zhu, Dongwang
Zhao, Xiulan
Zhang, Yanhui
Dong, Xueyi
Che, Na
Li, Jing
Liu, Fang
Zhao, Nan
Wang, Yong
Zhang, Danfang
author_sort Sun, Junying
collection PubMed
description High mobility group protein A2 (HMGA2) is a transcription factor that plays an important role in the invasion and metastasis of gastric carcinoma (GC). The term vasculogenic mimicry (VM) refers to the unique ability of aggressive tumour cells to mimic the pattern of embryonic vasculogenic networks. However, the relationship between HMGA2 and VM formation remains unclear. In the present study, we examined concomitant HMGA2 expression and VM in 228 human GC samples and 4 GC cell lines. Our data indicate that HMGA2 is not only significantly associated with VM formation but also influences the prognosis of patients with gastric carcinoma. Overexpression of HMGA2 significantly increased cell motility, invasiveness, and VM formation both in vitro and in vivo. A luciferase reporter assay, Co-IP and ChIP demonstrated that HMGA2 induced the expression of Twist1 and VE-cadherin by binding to the Twist1 promoter. Moreover, we observed a decrease in VE-cadherin following Twist1 knockdown in cells overexpressing HMGA2. This study indicates that HMGA2 promotes VM in GC via Twist1-VE-cadherin signalling and influences the prognosis of patients with GC.
format Online
Article
Text
id pubmed-5440402
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54404022017-05-25 HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma Sun, Junying Sun, Baocun Sun, Ran Zhu, Dongwang Zhao, Xiulan Zhang, Yanhui Dong, Xueyi Che, Na Li, Jing Liu, Fang Zhao, Nan Wang, Yong Zhang, Danfang Sci Rep Article High mobility group protein A2 (HMGA2) is a transcription factor that plays an important role in the invasion and metastasis of gastric carcinoma (GC). The term vasculogenic mimicry (VM) refers to the unique ability of aggressive tumour cells to mimic the pattern of embryonic vasculogenic networks. However, the relationship between HMGA2 and VM formation remains unclear. In the present study, we examined concomitant HMGA2 expression and VM in 228 human GC samples and 4 GC cell lines. Our data indicate that HMGA2 is not only significantly associated with VM formation but also influences the prognosis of patients with gastric carcinoma. Overexpression of HMGA2 significantly increased cell motility, invasiveness, and VM formation both in vitro and in vivo. A luciferase reporter assay, Co-IP and ChIP demonstrated that HMGA2 induced the expression of Twist1 and VE-cadherin by binding to the Twist1 promoter. Moreover, we observed a decrease in VE-cadherin following Twist1 knockdown in cells overexpressing HMGA2. This study indicates that HMGA2 promotes VM in GC via Twist1-VE-cadherin signalling and influences the prognosis of patients with GC. Nature Publishing Group UK 2017-05-22 /pmc/articles/PMC5440402/ /pubmed/28533522 http://dx.doi.org/10.1038/s41598-017-02494-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sun, Junying
Sun, Baocun
Sun, Ran
Zhu, Dongwang
Zhao, Xiulan
Zhang, Yanhui
Dong, Xueyi
Che, Na
Li, Jing
Liu, Fang
Zhao, Nan
Wang, Yong
Zhang, Danfang
HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma
title HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma
title_full HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma
title_fullStr HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma
title_full_unstemmed HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma
title_short HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma
title_sort hmga2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating twist1 in gastric carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440402/
https://www.ncbi.nlm.nih.gov/pubmed/28533522
http://dx.doi.org/10.1038/s41598-017-02494-6
work_keys_str_mv AT sunjunying hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT sunbaocun hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT sunran hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT zhudongwang hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT zhaoxiulan hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT zhangyanhui hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT dongxueyi hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT chena hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT lijing hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT liufang hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT zhaonan hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT wangyong hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma
AT zhangdanfang hmga2promotesvasculogenicmimicryandtumoraggressivenessbyupregulatingtwist1ingastriccarcinoma